Walgreens Boots Alliance (NYSE: WBA) 3Q19 Results: Slow Performance at Boots UK, Company Reviewing Its US Store Estate

Executive Summary

• Walgreens Boots Alliance reported marginal revenue growth of 0.7% in 3Q19, to $34.6 billion, in line with the consensus estimate. Diluted EPS came in at $1.13, down 16.3% year over year and below the consensus estimate of $1.19.
• Comps for the Retail Pharmacy USA business fell 1.1%, while Retail Pharmacy International comps decreased 6.8%.
• For FY19, Walgreens maintained guidance for roughly flat EPS at constant currency.